Haleos Labs Limited

  • BSE Code : 540679
  • NSE Symbol : HALEOSLABS
  • ISIN : INE320X01016
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,287.70 33.90(2.70%)

Open Price ()

1,197.60

Prev. Close ()

1,253.80

Volume (No’s)

603

Market Cap ()

389.31

Low Price ()

1,197.60

High Price ()

1,290.00

 

Corporate Announcement

30-Mar-2026 HALEOS LABS LIMITED - Updates
13-Feb-2026 HALEOS LABS LIMITED - Copy of Newspaper Publication
21-Jan-2026 HALEOS LABS LIMITED - Updates
13-Jan-2026 HALEOS LABS LIMITED - Updates
12-Nov-2025 SMS Lifesciences India Limited - Copy of Newspaper Publication

Stock Summary

Market Cap(₹Cr.)

392.72

P/E (TTM)

21.56

Book value ()

684.27

Div Yield (%)

0.12

EPS (TTM)

60.26

Face Value ()

10.00

Technical Analysis

Key Level

Resistance 1

1,272.83

Resistance 2

1,291.87

Support 1

1,215.73

Support 2

1,177.67

Moving Average

30 Days

1,267.00

50 Days

1,255.68

100 Days

1,285.26

200 Days

1,222.74

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Haleos Labs Limited 392.72 21.56 1.66 48.24 0.12 60.26
Sun Pharmaceutical Indust.. 406,603.30 93.16 17.11 7162.05 0.94 18.19
Divis Laboratories Ltd 155,484.95 60.44 10.27 3332 0.51 96.91
Torrent Pharmaceuticals L.. 135,009.27 60.45 14.42 3583.06 0.15 65.99
Lupin Ltd 104,090.54 18.82 3.81 5569.31 0.53 120.95

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 7156 0.24
Total Institutions 8782 0.29
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 92530 3.06
Total Promoters 2170576 71.80
Total Public & others 744243 24.62
Total 3023287 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006. The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector. The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016.

The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates. The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments. SMS Group was given the export house status in the year 1997-98.

Having three multi product facilities in operation and a research centre, the Company executed contract manufacturing and research assignment for global customer base. The Scheme of Arrangement between SMS Pharmaceuticals Limited with the Company was implemented in 2016-...

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew